Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol PR in Knee Osteoarthritis Pain
NCT00486811Phase 3Completed
- Sponsor
- Grünenthal GmbH
- Start
- Jun 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 13
01
Overview
Phase 3, randomised, double-blind trial of tapentadol in knee osteoarthritis (OA) (3 arms), sponsored by Grünenthal GmbH. Primary endpoint: Change From Baseline of the Average Pain Intensity Overall in the 12-week Maintenance Period. Started Jun 2007; status: completed.
02
Drugs
tapentadol
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00486811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00486811.